Envision Healthcare Holdings Given Neutral Rating at Credit Suisse (EVHC)
Envision Healthcare Holdings (NASDAQ:EVHC)‘s stock had its “neutral” rating reaffirmed by equities research analysts at Credit Suisse in a research note issued to investors on Friday. They currently have a $38.00 price objective on the stock, up from their previous price objective of $36.00. Credit Suisse’s price target would suggest a potential upside of 5.70% from the company’s current price.
A number of other firms have also recently commented on EVHC. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Envision Healthcare Holdings in a research note on Thursday. They now have a $43.00 price target on the stock, up previously from $41.00. Separately, analysts at Barclays raised their price target on shares of Envision Healthcare Holdings from $40.00 to $42.00 in a research note on Thursday. They now have an “overweight” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Envision Healthcare Holdings in a research note on Wednesday, July 23rd. They set a “market perform” rating on the stock. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $51.25.
Envision Healthcare Holdings (NASDAQ:EVHC) traded down 1.78% during mid-day trading on Friday, hitting $35.31. 823,300 shares of the company’s stock traded hands. Envision Healthcare Holdings has a 1-year low of $24.62 and a 1-year high of $38.02. The stock has a 50-day moving average of $35.42 and a 200-day moving average of $34.11. The company has a market cap of $6.396 billion and a price-to-earnings ratio of 280.86.
Envision Healthcare Holdings (NASDAQ:EVHC) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.04 billion. The company’s revenue for the quarter was up 19.6% on a year-over-year basis. Analysts expect that Envision Healthcare Holdings will post $1.16 EPS for the current fiscal year.
Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.